Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
ROCKVILLE, Md. (AP) _ Supernus Pharmaceuticals Inc. (SUPN) on Wednesday reported second-quarter profit of $23.7 million.
On a per-share basis, the Rockville, Maryland-based company said it had profit of 43 cents.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 17 cents per share.
The drugmaker posted revenue of $141.3 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $134.8 million.
Insight by Carahsoft: Learn about the efforts today and what’s on the horizon by civilian and the military services in rolling out 5G infrastructure and devices to improve mission effectiveness
Supernus expects full-year revenue in the range of $550 million to $580 million.
Supernus shares have risen 8% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $27.18, a climb of 18% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SUPN at https://www.zacks.com/ap/SUPN
© 2021 . All rights reserved. This website is not intended for users located within the European Economic Area.